peptide myostatin antagonists (Orico)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepeptide myostatin antagonists (Orico)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsWounds and InjuriesCachexiaSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrico Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrico Ltd
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesCachexiaSarcopenia

Other Information

ATC CodeN/A
Related LinksN/A